
|Articles|September 30, 2004
Group files complaint with FTC over sex supplement ads
A leading consumer advocacy group has filed a complaint with the Federal Trade Commission over what it says is deceptive advertising of a nutritional supplement known as Enzyte, which is designed to improve erectile function.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Mohit Khera, MD, recaps key takeaways from FDA panel on TRT for men
2
FDA approves first-line Zenflow system for the treatment of BPH
3
FDA approves niraparib plus abiraterone acetate with prednisone for BRCA2+ mCSPC
4
FDA approves zoliflodacin for uncomplicated urogenital gonorrhea
5















